Cargando…
Expression of the SARS-CoV-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer
Recent studies have revealed that cancer patients had a higher risk of having coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), compared to patients without cancer. The expression of angiotensin-converting enzyme 2 (ACE2), the receptor of SA...
Autores principales: | Zhang, Hongming, Quek, Kelly, Chen, Runzhe, Chen, Jibei, Chen, Baoan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391203/ https://www.ncbi.nlm.nih.gov/pubmed/32742475 http://dx.doi.org/10.7150/jca.49462 |
Ejemplares similares
-
COVID-19 Transmission Within a Family Cluster in Yancheng, China
por: Zhang, Hongming, et al.
Publicado: (2020) -
Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer
por: Zhang, Hongming, et al.
Publicado: (2019) -
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2
por: Suryamohan, Kushal, et al.
Publicado: (2021) -
Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022) -
Brentuximab vedotin for treatment of relapsed or refractory malignant lymphoma: results of a systematic review and meta-analysis of prospective studies
por: Chen, Runzhe, et al.
Publicado: (2015)